Advanced search
Publication Cover
Expert Opinion on Orphan Drugs Volume 4, 2016 - Issue 8
Submit an article Journal homepage
155
Views
8
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pembrolizumab for the treatment of advanced melanoma

Michael C. BurnsDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
,
Aidan O’donnellDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
&
Igor PuzanovDivision of Hematology-Oncology, Vanderbilt-Ingram Cancer Center; Vanderbilt University Medical Center, Nashville, TN, USACorrespondence[email protected]
Pages 867-873 | Received 11 Mar 2016, Accepted 16 May 2016, Published online: 07 Jun 2016

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Giulia Chiaruttini, Silvia Mele, James Opzoomer, Silvia Crescioli, Kristina M. Ilieva, Katie E. Lacy & Sophia N. Karagiannis. (2017) B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment. OncoImmunology 6:4.
Read now

Articles from other publishers (7)

Indu Sharma, Anuradha Sharma, Reena Tomer, Neha Negi & Ranbir Chander Sobti. 2023. Handbook of Oncobiology: From Basic to Clinical Sciences. Handbook of Oncobiology: From Basic to Clinical Sciences 1 29 .
Sanju Cyriac, Ajith Toms & Sunitha Thomas. (2021) Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma. South Asian Journal of Cancer 11:01, pages 082-083.
Crossref
Rangarirai Makuku, Neda Khalili, Sepideh Razi, Mahsa Keshavarz-Fathi & Nima Rezaei. (2021) Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy. Journal of Immunology Research 2021, pages 1-15.
Crossref
Chin-King Looi, Felicia Fei-Lei Chung, Chee-Onn Leong, Shew-Fung Wong, Rozita Rosli & Chun-Wai Mai. (2019) Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Mariarosaria Conte, Raffaele De Palma & Lucia Altucci. (2018) HDAC inhibitors as epigenetic regulators for cancer immunotherapy. The International Journal of Biochemistry & Cell Biology 98, pages 65-74.
Crossref
Edward J. WladisJoshua A. LeeJ. Andrew CarlsonNina MartinoAlejandro P. Adam. (2018) Programmed Death-1 Pathway in Orbital Invasion of Cutaneous Carcinomas. Ophthalmic Plastic & Reconstructive Surgery 34:2, pages 110-113.
Crossref
Nalini Marino, Sam Illingworth, Prithvi Kodialbail, Ashvin Patel, Hugo Calderon, Rochelle Lear, Kerry D. Fisher, Brian R. Champion & Alice C. N. Brown. (2017) Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes. PLOS ONE 12:5, pages e0177810.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.